NCT00082602 Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT00074529 Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED) Status COMPLETED Phase PHASE2
NCT00069849 A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT00056524 Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) Status COMPLETED Phase PHASE3
NCT00056225 VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study) Status COMPLETED Phase PHASE3
NCT00051909 Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00031018 Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha Status UNKNOWN Phase PHASE2
NCT00021723 Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease Status TERMINATED Phase PHASE2
NCT00018343 Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen Status COMPLETED Phase PHASE2
NCT00013650 Effects of an Anti-Inflammatory Drug in Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT00012831 Nurse Managed Clinic for Dementia Patients and Family Caregivers Status COMPLETED Phase N/A